Category: Feature Stories

In the worldwide race for a corona vaccine, another research project has reported a decisive success. In an interim analysis, the corona vaccine of the US biotech company Moderna showed an efficacy of 94.5 percent in protecting against Covid-19. Moderna expects to be able to apply for emergency approval in the USA in the coming weeks, the company announced on Monday. Over 90 percent protectionModerna is the second major U.S. pharmaceutical company to present positive data from the pivotal study with a corona vaccine within one week. Last Monday, the…

Read More

The co-founder of the vaccine developer Biontech, Ugur Sahin, expects a return to normality by winter 2021, but to achieve this it is “absolutely essential” to achieve a high vaccination rate against the corona virus before autumn, he told the British television channel BBC today. However, he was optimistic that this could be achieved. The vaccine developed by Biontech and the US pharmaceutical giant Pfizer is one of the most promising products in the fight against the pandemic. “Hard Winter”Sahin announced that the developed vaccine would be delivered as early…

Read More

Caritas President Michael Landau has made an appeal for social cohesion and confidence in the face of the Corona crisis, the recent lockdown and the Islamist terrorist attack in Vienna. “Charity does not go into the lockdown”, said Landau during a service on Sunday in St. Stephen’s Cathedral on the occasion of the church’s “World Day of the Poor”. The willingness to stand together, to tackle and not to forget the weakest had made Austria great in the past, the Caritas President stressed. “We should continue on this path in…

Read More

The number of confirmed coronavirus infections in the EU and other European countries has doubled to more than ten million within only three and a half weeks. By Friday, a total of 10,124,110 cases had been reported in the European Economic Area including the UK. This is almost 242,000 more than the day before. It was only on October 20 that the mark of five million proven infections was exceeded.According to the daily survey of the European Centre for Disease Prevention and Control (ECDC), most infections have now been registered…

Read More

The news about a new corona vaccine gives hope. How does it work? And when could it be used in Austria? We get to the bottom of the most important questions. What is known about the effect of the vaccine so far?According to the German company Biontech and the pharmaceutical company Pfizer, the vaccine candidate BNT162b2 is said to offer a 90 percent protection rate. Serious side effects have not been registered to date. This information is based on interim results of the Phase 3 study, which is crucial for…

Read More

Corona. Lockdown. All over again? Not quite, but the newly imposed lockdown light is still a huge psychological blow to all of us. When the Corona pandemic brought everything to a standstill in the spring, the summer was full of rays of hope. And it gave us courage. Now not only are all restaurants, bars and museums closing again, but we are also facing the darkest, dimmest and longest season of the year. A low mood or even depression is pre-programmed. Corona Lockdown light: How it affects the psycheGeneral frustration…

Read More

Following the supply agreement between the EU and the pharmaceutical companies BioNTech and Pfizer, Health Minister Rudolf Anschober (Greens) is optimistic that it will be possible to vaccinate risk groups and health workers against the coronavirus in the first quarter of 2021. “I assume that the other interested population can then be vaccinated step by step from the second quarter onwards. We are currently preparing the vaccination logistics for this,” he explained in a press release on Wednesday. The Ministry of Health has emphasized that the vaccination should first be…

Read More

A novel vaccination is to provide 90 percent protection against the coronavirus. The pharmaceutical companies Pfizer and Biontech have developed a vaccine that is expected to offer 90 percent protection against corona disease. It has already been tested on 43,500 people. One of them is the Austrian virologist and top researcher Florian Krammer. He cheered: “For the first time we are seeing a vaccine that works. The vaccine uses a completely experimental approach, which involves injecting part of the virus’s genetic code into people, in order to train the immune…

Read More

About 54 percent of the Austrians would be vaccinated against COVID-19, should there be a vaccine. This is the result of a representative online survey conducted by GfK among 1,005 participants between the end of September and the beginning of October. Almost half of the respondents stated that they had been psychologically stressed by the initial restrictions. However, this situation had improved after the end of the lockdown, the results were presented. “2020 is a very challenging year. None of us would have known in January how the following ten…

Read More